U.S. market Closed. Opens in 1 day 2 hours 2 minutes

SPRY | ARS Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue30.00K1.32M5.51M17.84MN/AN/A
Cost of Revenue73.00K17.32M20.27M14.07M1.55M1.42M
Gross Profit-43.00K-16.00M-14.77M3.77M-1.55M-1.42M
Operating Expenses67.55M36.83M24.96M18.30M22.52M16.90M
Selling, General & Admin47.28M18.46M4.69M4.23M1.02M2.10M
Research & Development20.27M18.38M20.27M14.07M21.50M14.80M
Other Operating ExpensesN/A974.00K-789.00K-596.00KN/AN/A
Operating Income-67.52M-35.52M-19.45M-469.00K-24.07M-18.32M
Other Expenses / Income13.15M834.00K-789.00K-596.00K100.00K741.00K
Before Tax Income-54.37M-34.68M-20.24M-1.06M-23.97M-17.58M
Income Tax ExpensesN/A-694.00K-230.56K-200.30KN/AN/A
Net Income-54.37M-33.99M-20.24M-1.06M-23.97M-17.58M
Interest ExpensesN/AN/A106.00K29.00KN/AN/A
Basic Shares Outstanding95.22M39.96M28.87M34.70M33.07M33.07M
Diluted Shares Outstanding95.22M39.96M28.87M34.70M33.07M33.07M
EBITDA-67.45M-35.52M-19.24M-463.00K-22.52M-16.90M
EBITDA Margin-224,823.33%-2,698.78%-349.46%-2.60%0.00%0.00%
EBIT-54.37M-34.68M-20.37M-1.24M-23.97M-17.58M
EBIT Margin-181,216.67%-2,635.41%-369.92%-6.93%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙